Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15364 | 646 | 29.4 | 49% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHOLESTERYL ESTER STORAGE DISEASE | Author keyword | 99 | 97% | 4% | 29 |
2 | LYSOSOMAL ACID LIPASE | Author keyword | 61 | 78% | 6% | 40 |
3 | WOLMAN DISEASE | Author keyword | 53 | 85% | 4% | 28 |
4 | CHOLESTEROL ESTER STORAGE DISEASE | Author keyword | 20 | 100% | 1% | 9 |
5 | LYSOSOMAL ACID LIPASE DEFICIENCY | Author keyword | 17 | 100% | 1% | 8 |
6 | WOLMANS DISEASE | Author keyword | 11 | 100% | 1% | 6 |
7 | ACID LIPASE | Author keyword | 8 | 56% | 2% | 10 |
8 | NEUTRAL CHOLESTEROL ESTERASE | Author keyword | 7 | 67% | 1% | 6 |
9 | CHOLESTERYL ESTER HYDROLYSIS | Author keyword | 5 | 50% | 1% | 7 |
10 | CHOLESTERYL ESTER HYDROLASE | Author keyword | 4 | 36% | 2% | 10 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | WOLMAN DISEASE | 63 | 83% | 5% | 35 |
2 | SPLICE JUNCTION MUTATION | 31 | 76% | 3% | 22 |
3 | CESD | 31 | 92% | 2% | 12 |
4 | ESTER STORAGE DISEASE | 28 | 57% | 5% | 33 |
5 | LYSOSOMAL ACID LIPASE | 27 | 47% | 7% | 42 |
6 | WOLMANS DISEASE | 10 | 73% | 1% | 8 |
7 | LAL MICE | 8 | 100% | 1% | 5 |
8 | EMR1A 212D RECOGNIZING SITE | 6 | 100% | 1% | 4 |
9 | SUBCLINICAL COURSE | 4 | 75% | 0% | 3 |
10 | WOLMAN | 4 | 75% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cholesteryl ester storage disease: Review of the findings in 135 reported patients with an underdiagnosed disease | 2013 | 22 | 89 | 90% |
Lysosomal acid lipase deficiency - An under-recognized cause of dyslipidaemia and liver dysfunction | 2014 | 8 | 64 | 64% |
Regulation of Lipid Droplet Cholesterol Efflux From Macrophage Foam Cells | 2012 | 38 | 49 | 37% |
Macrophage cholesteryl ester mobilization and atherosclerosis | 2010 | 41 | 70 | 44% |
Lysosomal acid lipase A and the hypercholesterolaemic phenotype | 2013 | 12 | 55 | 47% |
Early steps in reverse cholesterol transport: cholesteryl ester hydrolase and other hydrolases | 2012 | 5 | 41 | 44% |
WOLMAN-DISEASE AND ITS TREATMENT | 1995 | 15 | 31 | 68% |
The Role of Neutral Cholesterol Ester Hydrolysis in Macrophage Foam Cells | 2011 | 9 | 44 | 25% |
Overexpression of lysosomal acid lipase and other proteins in atherosclerosis | 2006 | 13 | 124 | 19% |
Lysosomal acid lipase and atherosclerosis | 2004 | 12 | 37 | 32% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED HLTH SCI NUTR | 2 | 67% | 0.3% | 2 |
2 | HLTH TECHNOL BIOCHEM | 1 | 100% | 0.3% | 2 |
3 | IU SIMON CANC | 1 | 15% | 1.2% | 8 |
4 | ARIZONA HLTH SCI RADIOL | 1 | 50% | 0.2% | 1 |
5 | HEMATOL ONCOL BLOOD BONE MARROW TRANSPLANTA | 1 | 50% | 0.2% | 1 |
6 | IST SCI SAN RAFFAELE HOSP | 1 | 50% | 0.2% | 1 |
7 | LIPID SCI SECT | 1 | 50% | 0.2% | 1 |
8 | OR WELF COOPERAT | 1 | 50% | 0.2% | 1 |
9 | ARIZONA HLTH SCI CHILDRENS | 0 | 33% | 0.2% | 1 |
10 | BIOCHIM MED MALAD METAB | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000172172 | ACAT INHIBITOR//ARTERIOSCLEROSIS PROGRAM//ACYL COA CHOLESTEROL ACYLTRANSFERASE ACAT |
2 | 0.0000167104 | BILE SALT DEPENDENT LIPASE//CHOLESTEROL ESTERASE//CARBAMATE INHIBITORS |
3 | 0.0000150741 | CONTINUOUS NORMOBARIC HYPOXIA//BIOMED SCI DALTON CARDIOVASC//GLUTATHIONE RELATED ENZYME |
4 | 0.0000145719 | FARBER DISEASE//ASAH1//FARBER LIPOGRANULOMATOSIS |
5 | 0.0000126979 | AGE RELATED DECREASE IN PGI2 PRODUCTION//EN FACE TECHNIQUE//15 ISOPROSTANE F 2T |
6 | 0.0000097175 | PERILIPIN//LIPID DROPLET//ADIPOSE TRIGLYCERIDE LIPASE |
7 | 0.0000084610 | ELECTRONEGATIVE LDL//ELECTRONEGATIVE LOW DENSITY LIPOPROTEIN//ENZYMATICALLY MODIFIED LDL |
8 | 0.0000073117 | CARBOXYLESTERASE//DRUG METAB BIOPHARMACEUT//CARBOXYLESTERASES |
9 | 0.0000063670 | SCAVENGER RECEPTOR//FRACTIONATED H 3HEPARIN//CLASS A SCAVENGER RECEPTOR |
10 | 0.0000061877 | ANTIOXIDANT PHARMACOL//NITROSONIFEDIPINE//MYOCYTE MIGRATION |